Resumo

ALFONSO RODRIGUEZ, Emilio; LLERENA ROJAS, Lorenzo Daniel  e  RODRIGUEZ NANDE, Lidia María. Considerations for patients with cardiovascular diseases during the COVID-19 pandemic. Rev Cubana Invest Bioméd [online]. 2020, vol.39, n.3  Epub 01-Set-2020. ISSN 1561-3011.

The infectious disease caused by the new coronavirus-2019 (COVID-19), produces an acute respiratory syndrome with significant implications for the cardiovascular system both in patients with pre-existing cardiovascular disease (CVD), who have a risk of worsening their disease and death, such as those in which the infection has been associated with multiple direct and indirect cardiovascular complications. The cardiovascular complications most frequently associated with this entity include acute myocardial injury, myocarditis, acute coronary syndromes, arrhythmias, and venous thromboembolism. Furthermore, the therapies used to treat COVID-19 disease may have drug interactions with cardiovascular drugs, darkening the prognosis of the patients. The present work attempts to highlight the different recommendations made by experts in the medical literature regarding cardiovascular complications related to the new coronavirus (COVID-19).

Palavras-chave : coronavirus; cardiovascular therapy; COVID-19 therapy.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )